Omics

#Cancer research #Macomics #Macrophages #Omics #Oncology #Tumour microenvironment (TME) #Turning Science into Business

Turning science into business: Exploiting macrophage biology

DDW’s Diana Spencer chats to Macomics’ co-founder and VP Immunology Dr Luca Cassetta about the company’s approach to tumour suppression and the challenges of launching a new business in early 2020. DS: Congratulations on the publication of your discoveries in Nature Reviews Cancer. Your studies focus on tumour associated macrophages (TAMs). What role… Read More

#Cancer Research #Exclusive Content

Cutting the red ribbon
#Drug discovery #Omics #PerkinElmer #Preclinical development #Revvity

PerkinElmer’s Life Science and Diagnostics business becomes Revvity

PerkinElmer’s Life Science and Diagnostics business has revealed its new name and branding. Revvity has now officially launched as a science-based solutions company. Based on two words, ‘revolutionise’ (rev) and ‘vita’ (vit) meaning ‘life’ in Latin, Revvity will provide reagents, consumables, assays, instruments and software to customers… Read More

#Business & Investment #News

#AI / data analytics / healthtech / informatics #Bioinformatics #Drug development #Drug discovery #Emmes #Omics #Personalised medicine #Systems biology

How big data analytics can make personalised care a reality

Johannes Goll, Global Head of Emmes’ Biomedical Data Science and Bioinformatics department, explains how big data analytics can deliver improved therapies and bring clinical research one step close to realising the potential of personalised care. A key breakthrough area where big data analytics has shown tremendous scope and application is… Read More

#Exclusive Content #Opinion

Tick bite
#Biomarkers #Genetic profiling #Immunity #Lyme Disease #mRNA #Omics #RNA sequencing

Genetic profiling of Lyme disease could bring new therapeutic targets 

Researchers have identified 35 genes associated with long-term Lyme disease that could potentially be used as biomarkers to diagnose patients with the condition.  The findings, from the Icahn School of Medicine at Mount Sinai in New York and published in the journal Cell… Read More

#News